Overcoming market access hurdles will be a challenge for a newly approved drug for major depressive disorder, Auvelity. But, a favorable efficacy and adverse event profile will likely help to facilitate patient access.
The first installment in a series that will explain a recent and revolutionary cell therapy called CAR T, delving into current successes and future opportunities.
A new study from the Medical College of Georgia at Augusta University has found that irrigating your nose twice a day with a saline solution after testing positive for Covid-19 can decrease your chances of hospitalization and death in higher-risk patie…
Recent discoveries in Alzheimer’s disease research have thrown into question fundamental assumptions about the disease and its origins. In the second installment of this series, we introduce the primary risk factor of Alzheimer’s and how it may cause c…
UnitedHealth Group’s Optum unit Monday completed its proposed $13 billion acquisition of the software and data analytics firm Change Healthcare after successfully fending off a U.S. Justice Department challenge of the deal.